Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects



Rating:

Share or cite this content

Citations should be made in the following way:
J. Smith (Manchester (Greater Manchester), United Kingdom), K. Holt (Manchester (Greater Manchester), United Kingdom), R. Dockry (Manchester (Greater Manchester), United Kingdom), H. Thornton (Ennis, Ireland), F. Keane (Ennis, Ireland), K. Mcguinness (Manchester, United Kingdom). Cough monitoring during the covid-19 pandemic. 957

Member's Comments

No comment yet.

Related content which might interest you: Preventing the next influenza pandemic Source: International Congress 2015 – PG11 Emerging infectious diseases and pandemic planning Year: 2015 Management of respiratory diseases in the COVID-19 pandemic Source: COVID-19 Videos Year: 2020 Asthma management and control during COVID-19 pandemic Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Pneumonia and pandemic influenza virus A (H1N1/09). Immediate and remote results Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Potential and limits of NIV in pandemic respiratory infections Source: Annual Congress 2013 –PG11 NIV in growth areas Year: 2013 The severity of pandemic H1N1 influenza in Albania Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 A physiological-social score for triaging of pandemic influenza patients Source: Eur Respir J 2006; 28: Suppl. 50, 631s Year: 2006 A physiological-social score for triaging of pandemic influenza patients Source: Eur Respir J 2006; 28: 253-254 Year: 2006 Evaluation of pneumonia cases due to pandemic influenza A (H1N1) Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010 Early use of oseltamivir protected from respiratory failure in patients with acute flu syndrome during 2009 Brazilian influenza H1N1 pandemics Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010 Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Arterial hypoxemia and diminished immune response at admission predict poor outcome in patients with viral-bacterial pneumonia during flu H1N1 pandemic period Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Characteristics and outcome of pneumonia in patients with 2009 pandemic influenza A/H1N1. Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Hospitalizations from pandemic influenza (pH1N1) infections among patients with asthma in Spain Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Influenza activity in Serbia during pandemic Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010 Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks Source: Eur Respir J, 56 (3) 2001400; 10.1183/13993003.01400-2020 Year: 2020 Hospitalizations from pandemic influenza (pH1N1) infections among patients with COPD in Spain Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Sleep disordered breathing management in China during the COVID-19 pandemic Source: Virtual Congress 2020 – Chinese programme 2020: Part II Year: 2020 Influenza: from zoonosis to pandemic Source: ERJ Open Res 2016 Year: 2016